Plain-English translation of NCT07127510 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study that measures levels of NAD, a natural chemical found in the brain, in people with Alzheimer's disease and in healthy older adults without the disease. Researchers want to find out whether people with Alzheimer's have lower NAD levels than people without the disease, which could help explain how Alzheimer's develops.
Scientists believe that NAD levels may play a role in Alzheimer's disease. By comparing brain NAD levels between people with and without Alzheimer's, researchers hope to better understand the disease and potentially find new ways to treat it.
You likely qualify if…
You likely don't qualify if…
You will have two brain imaging appointments at Florida Atlantic University, about 8 months apart. During each visit, you'll lie still inside an MRI machine (a large scanner) while it takes detailed pictures of your brain to measure NAD levels. Each imaging session takes a few hours. There are no injections, blood draws, or medications involved.
AI-generated summary from trial data · Jul 21, 2026 · Not medical advice
United States
Enrollment target
~20 participants
Started
March 2026
Primary completion
April 2027
Age range
65 Years – 80 Years
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
FAU Clinical Research Unit Central Contact
Florida Atlantic University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.